ASB3通过在 TRAIL 耐药性中调解 DR5 无化,促进肝细胞癌的进展
Linlin Huang1,2, Zhihui Che1, Fuchen Liu3
1Central Laboratory, Huashan Hospital, Fudan University, Shanghai, China.
概括
安基林重复和SOCS盒蛋白3 (ASB3) 对肝癌 (HCC) 的发展至关重要. 向ASB3可能会改善治疗结果,并克服对瘤亡因子相关的亡诱导配体 (TRAIL) 治疗的抗性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 具有细胞因子信号盒抑制剂 (ASB) 蛋白质的安基林重复蛋白质是E3泛基因连接酶,其功能基本上未知.
- 肝细胞癌 (HCC) 仍然是一个重大的全球健康挑战,治疗选择有限.
研究的目的:
- 研究ASB3在肝细胞癌 (HCC) 发展中的作用.
- 探索ASB3作为HCC治疗点的潜力.
主要方法:
- 在HCC组织中进行ASB3表达分析.
- 在体外和体外功能测定 (细胞生长停止,细胞亡,瘤抑制).
- 涉及蛋白质与蛋白质相互作用,无处不在和降解试验的机制研究.
主要成果:
- 高ASB3表达与HCC预后不佳相关.
- ASB3沉默抑制了HCC细胞的生长,并诱导了细胞亡.
- ASB3促进了死亡受体5 (DR5) 的泛化和降解.
- 通过稳定DR5.5,ASB3敲击使HCC细胞对TRAIL处理敏感.
结论:
- 通过促进DR5降解,ASB3对HCC发展至关重要.
- 针对ASB3可能是一个可行的策略,以提高HCC治疗效率和克服TRAIL耐药性.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


